Literature DB >> 20970212

Symptoms 10-17 years after breast cancer radiotherapy data from the randomised SWEBCG91-RT trial.

Dan Lundstedt1, Magnus Gustafsson, Per Malmström, Karl-Axel Johansson, David Alsadius, Agnetha Sundberg, Ulrica Wilderäng, Erik Holmberg, Harald Anderson, Gunnar Steineck, Per Karlsson.   

Abstract

BACKGROUND: Postoperative radiotherapy decreases the risk for local recurrence and improves overall survival in women with breast cancer. We have limited information on radiotherapy-induced symptoms 10-17 years after therapy.
MATERIAL AND METHODS: Between 1991 and 1997, women with lymph node-negative breast cancer were randomised in a Swedish multi-institutional trial to breast conserving surgery with or without postoperative radiotherapy. In 2007, 10-17 years after randomisation, the group included 422 recurrence-free women. We collected data with a study-specific questionnaire on eight pre-selected symptom groups.
RESULTS: For six symptom groups (oedema in breast or arm, erysipelas, heart symptoms, lung symptoms, rib fractures, and decreased shoulder mobility) we found similar occurrence in both groups. Excess occurrence after radiotherapy was observed for pain in the breast or in the skin, reported to occur "occasionally" by 38.1% of survivors having undergone radiotherapy and surgery versus 24.0% of those with surgery alone (absolute difference 14.1%; p=0.004) and at least once a week by 10.3% of the radiotherapy group versus 1.7% (absolute difference 8.6%; p=0.001). Daily life and analgesic use did not differ between the groups.
CONCLUSIONS: Ten to 17 years after postoperative radiotherapy 1 in 12 women had weekly pain that could be attributed to radiotherapy. The symptoms did not significantly affect daily life and thus the reduced risk for local recurrence seems to outweigh the risk for long-term symptoms for most women.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20970212     DOI: 10.1016/j.radonc.2010.09.018

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  9 in total

Review 1.  Cancer treatment-related neuropathic pain syndromes--epidemiology and treatment: an update.

Authors:  Ellen M Lavoie Smith; Celia M Bridges; Grace Kanzawa; Robert Knoerl; James P Kelly; Anna Berezovsky; Charis Woo
Journal:  Curr Pain Headache Rep       Date:  2014-11

Review 2.  Risk factors of pain in breast cancer survivors: a systematic review and meta-analysis.

Authors:  Laurence Leysen; David Beckwée; Jo Nijs; Roselien Pas; Thomas Bilterys; Sofie Vermeir; Nele Adriaenssens
Journal:  Support Care Cancer       Date:  2017-08-10       Impact factor: 3.603

3.  Radiotherapy of early breast cancer in scleroderma patients: our experience with four cases and a short review of the literature.

Authors:  George Kyrgias; Kiki Theodorou; Anna Zygogianni; Konstantinos Tsanadis; Stefanos Zervoudis; John Tzitzikas; Michael Koukourakis
Journal:  Breast Cancer (Dove Med Press)       Date:  2012-01-24

4.  Bi-tangential hybrid IMRT for sparing the shoulder in whole breast irradiation.

Authors:  P Farace; M A Deidda; I Iamundo de Cumis; I Iamundo de Curtis; E Deiana; R Farigu; G Lay; S Porru
Journal:  Strahlenther Onkol       Date:  2013-10-10       Impact factor: 3.621

5.  Characterization of risk factors for adjuvant radiotherapy-associated pain in a tri-racial/ethnic breast cancer population.

Authors:  Eunkyung Lee; Cristiane Takita; Jean L Wright; Isildinha M Reis; Wei Zhao; Omar L Nelson; Jennifer J Hu
Journal:  Pain       Date:  2016-05       Impact factor: 7.926

6.  Genome-wide enriched pathway analysis of acute post-radiotherapy pain in breast cancer patients: a prospective cohort study.

Authors:  Eunkyung Lee; Cristiane Takita; Jean L Wright; Susan H Slifer; Eden R Martin; James J Urbanic; Carl D Langefeld; Glenn J Lesser; Edward G Shaw; Jennifer J Hu
Journal:  Hum Genomics       Date:  2019-06-13       Impact factor: 4.639

7.  Breast cancer hypoxia in relation to prognosis and benefit from radiotherapy after breast-conserving surgery in a large, randomised trial with long-term follow-up.

Authors:  Julia Tutzauer; Martin Sjöström; Erik Holmberg; Per Karlsson; Fredrika Killander; L M Fredrik Leeb-Lundberg; Per Malmström; Emma Niméus; Mårten Fernö; Annika Jögi
Journal:  Br J Cancer       Date:  2022-02-09       Impact factor: 9.075

8.  Predictors of radiotherapy induced bone injury (RIBI) after stereotactic lung radiotherapy.

Authors:  Mojgan Taremi; Andrew Hope; Patricia Lindsay; Max Dahele; Sharon Fung; Thomas G Purdie; David Jaffray; Laura Dawson; Andrea Bezjak
Journal:  Radiat Oncol       Date:  2012-09-17       Impact factor: 3.481

9.  Recurrent erysipelas--risk factors and clinical presentation.

Authors:  Malin Inghammar; Magnus Rasmussen; Adam Linder
Journal:  BMC Infect Dis       Date:  2014-05-18       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.